Radioimmunotherapy of refractory non-Hodgkin's lymphoma with 131I-labeled chimeric 81C6 anti-tenascin monoclonal antibody:: Dosimetry study.

被引：0
|
作者：
Akabani, G [1 ]
Rizzieri, D [1 ]
Coleman, RE [1 ]
Metzler, SD [1 ]
Zalutsky, MR [1 ]
Bigner, DD [1 ]
机构：
[1] Duke Univ, Med Ctr, Durham, NC 27706 USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 2002年 / 43卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1259
引用
收藏
页码：313P / 313P
页数：1
相关论文
共 50 条
  • [41] Salvage radioimmunotherapy with murine iodine-131-labeled antitenascin monoclonal antibody 81C6 for patients with recurrent primary and metastatic malignant brain tumors: Phase II study results
    Reardon, DA
    Akabani, G
    Coleman, RE
    Friedman, AH
    Friedman, HS
    Herndon, JE
    McLendon, RE
    Pegram, CN
    Provenzale, JM
    Quinn, JA
    Rich, JN
    Vredenburgh, JJ
    Desjardins, A
    Guruangan, S
    Badruddoja, M
    Dowell, JM
    Wong, TZ
    Zhao, XG
    Zalutsky, MR
    Bigner, DD
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (01) : 115 - 122
  • [42] Phase I study of chimeric anti-CD20 monoclonal antibody in Chinese patients with CD20-positive non-Hodgkin's lymphoma
    Gui, Lin
    Han, Xiaohong
    He, Xiaohui
    Song, Yuanyuan
    Yao, Jiarui
    Yang, Jianliang
    Liu, Peng
    Qin, Yan
    Zhang, Shuxiang
    Zhang, Weijing
    Gai, Wenlin
    Xie, Liangzhi
    Shi, Yuankai
    CHINESE JOURNAL OF CANCER RESEARCH, 2016, 28 (02) : 197 - 208
  • [43] Treatment of refractory Hodgkin's lymphoma patients with an iodine-131-labeled murine anti-CD30 monoclonal antibody
    Schnell, R
    Dietlein, M
    Staak, JO
    Borchmann, P
    Schomaecker, K
    Fischer, T
    Eschner, W
    Hansen, H
    Morschhauser, F
    Schicha, H
    Diehl, V
    Raubitschek, A
    Engert, A
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (21) : 4669 - 4678
  • [44] Phase I study of chimeric anti-CD20 monoclonal antibody in Chinese patients with CD20-positive non-Hodgkin's lymphoma
    Lin Gui
    Xiaohong Han
    Xiaohui He
    Yuanyuan Song
    Jiarui Yao
    Jianliang Yang
    Peng Liu
    Yan Qin
    Shuxiang Zhang
    Weijing Zhang
    Wenlin Gai
    Liangzhi Xie
    Yuankai Shi
    Chinese Journal of Cancer Research, 2016, (02) : 197 - 208
  • [45] Iodine-131 anti-B1 antibody therapy in non-Hodgkin's lymphoma: Dosimetry and clinical implications
    Wahl, RL
    JOURNAL OF NUCLEAR MEDICINE, 1998, 39 (08) : 1S - 1S
  • [46] Phase I studies of radiolabeled I-131-81C6 anti-tenascin monoclonal antibody in patients with recurrent cystic gliomas or surgically created brain tumor resection cavities: Preliminary results
    Brown, MT
    Coleman, RE
    Friedman, AF
    Friedman, HS
    Perry, JR
    McLendon, RE
    Bigner, SH
    Zalutsky, MR
    Schold, SC
    Bigner, DD
    NEUROLOGY, 1996, 46 (02) : 66002 - 66002
  • [47] Pharmacokinetics, dosimetry, and initial therapeutic results with 131I- and 111In-/90Y-labeled humanized LL2 anti-CD22 monoclonal antibody in patients with relapsed, refractory non-Hodgkin's lymphoma
    Juweid, ME
    Stadtmauer, E
    Hajjar, G
    Sharkey, RM
    Suleiman, S
    Luger, S
    Swayne, LC
    Alavi, A
    Goldenberg, DM
    CLINICAL CANCER RESEARCH, 1999, 5 (10) : 3292S - 3303S
  • [48] Phase I trial results of iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with newly diagnosed malignant gliomas
    Cokgor, I
    Akabani, G
    Kuan, CT
    Friedman, HS
    Friedman, AH
    Coleman, RE
    McLendon, RE
    Bigner, SH
    Zhao, XG
    Garcia-Turner, AM
    Pegram, CN
    Wikstrand, CJ
    Shafman, TD
    Herndon, JE
    Provenzale, JM
    Zalutsky, MR
    Bigner, DD
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (22) : 3862 - 3872
  • [49] Randomized controlled study of I-131-Anti-B1 versus unlabeled-Anti-B1 monoclonal antibody in patients with chemotherapy refractory low grade non-Hodgkin's lymphoma
    Knox, SJ
    Goris, ML
    Davis, TA
    Trisler, KD
    Saal, J
    Levy, R
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 39 (02): : 326 - 326
  • [50] I-131-Anti-CD45 Radioimmunotherapy Effectively Targets and Treats T-Cell Non-Hodgkin's Lymphoma
    Gopal, Ajay K.
    Press, Oliver W.
    Fromm, Jonathan R.
    Wilbur, Shani
    Pagel, John M.
    BLOOD, 2008, 112 (11) : 325 - 325
12345